Ledger.Open graph →
SEC Form D · Amendment · filed May 14, 2018

Neurana Pharmaceuticals, Inc

Offering
$3.8M
Sold
$3.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
San Diego, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Alex F. Zisson · San Diego, CADirectorBrian F. Dorsey · San Diego, CADirectorDavid F. Hale · San Diego, CAExec · DirectorJoshua F. Richardson · San Diego, CADirectorKathleen D. Scott · San Diego, CAExecJudy Caron · San Diego, CAExecDaniel F. Becker · San Diego, CADirectorDavid F. Kabakoff · San Diego, CADirectorHal W. Reynolds · Los Angeles, CAExecCaleb S. Hernandez · Denver, CODirectorThomas D. Stevens · Los Angeles, CAExecAaron P. Reitkopf · EDEN PRAIRIE, MNDirectorDaniel E. Allen · Los Angeles, CADirectorDaniel S. Hoffman · DENVER, CODirectorColin Campbell · Clinton, WAExec · DirectorSteve R. Rubin · Denver, CODirectorHugh M. Mackworth · Portland, ORExec · DirectorPaul Touchstone · SAN FRANCISCO, CADirectorTim Mcdowell · San Francisco, CAExecGabriel M. Paez · Portland, ORExecBrewster Johnson · El Segundo, CADirectorAndrew Denardo · Red Bank, NJDirectorAnthony Grosso · Red Bank, NJDirectorJohn J. Pierrepont · San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗